Eshbal Functional Food (ESBL) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
26 Jun, 2026Business overview and product innovation
Specializes in vegan, low-carb, protein-rich, gluten-free foods and supplements for health-conscious consumers.
Operates a 60,000 sq.ft. facility in Israel with 70+ employees and proprietary in-house R&D.
Product range includes gluten-free breads, pita, flours, superfoods, enriched snack bars, and supplements.
Over 20 years of expertise in gluten-free and 'Better For You' product development.
Market opportunity and expansion strategy
North American gluten-free market valued at $2.98B in 2024, growing 9-11% annually.
Canada serves as a strategic base for North American expansion, leveraging local ingredient ecosystem and favorable economics.
Expansion includes organic growth, M&A (acquisitions of Gluten Free Nation and Dare To Be Different Foods), and local operations.
Retail and foodservice presence expanding, with production and sales initiated in Q1 2026.
Financial performance and growth outlook
Generated $13.8M in revenue in 2025, with Q1 2026 marking a record $5.4M quarter.
Forecasted revenue growth to $20M in 2026 and $40M by 2028, with gross margins projected to remain above 20%.
Four operational production sites and two completed acquisitions support scaling.
Latest events from Eshbal Functional Food
- Q1 2026 revenue surged 43% year-over-year, fueled by acquisitions and North American growth.ESBL
Q1 20262 Jun 2026 - Expanding in North America with innovative gluten-free foods and strong revenue growth.ESBL
Corporate presentation20 Mar 2026 - Q3 revenue up 25% with margin gains; RTO expense led to net loss, North America expansion underway.ESBL
Q3 202511 Dec 2025